Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease ; volume:10 ; number:1 ; day:15 ; month:3 ; year:2024 ; pages:1-10 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (15.3.2024), 1-10, 12.2024
- Urheber
-
Peball, Marina
Heim, Beatrice
Carbone, Federico
Schorr, Oliver
Werkmann, Mario
Ellmerer, Philipp
Marini, Kathrin
Krismer, Florian
Knaus, Hans-Günther
Poewe, Werner
Djamshidian, Atbin
Seppi, Klaus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00665-7
- URN
-
urn:nbn:de:101:1-2405172120481.389821813752
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peball, Marina
- Heim, Beatrice
- Carbone, Federico
- Schorr, Oliver
- Werkmann, Mario
- Ellmerer, Philipp
- Marini, Kathrin
- Krismer, Florian
- Knaus, Hans-Günther
- Poewe, Werner
- Djamshidian, Atbin
- Seppi, Klaus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Sleep disorders in Parkinson’s disease
Parkinson's disease and obstructive sleep apnea
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Recognition and diagnosis of sleep disorders in Parkinson’s disease
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Sleep disorders in Parkinson’s disease, an early and multiple problem
Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Sleep disorders in Parkinson’s disease
Parkinson's disease and obstructive sleep apnea
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Recognition and diagnosis of sleep disorders in Parkinson’s disease
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Sleep disorders in Parkinson’s disease, an early and multiple problem
Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Sleep disorders in Parkinson’s disease
Parkinson's disease and obstructive sleep apnea
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Recognition and diagnosis of sleep disorders in Parkinson’s disease
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Sleep disorders in Parkinson’s disease, an early and multiple problem
Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients